Cystic Fibrosis Therapy

Immunotherapy with IgY is by design a low toxicity treatment and is therefore ideally suited for long term prophylaxis, even more so for conditions where it is simply not possible to stay away from the microorganisms that cause the infection.

This is exactly the situation for Cystic fibrosis patients. IMMUNSYSTEM's drug candidate, Anti-Pseudomonas IgY, is a daily treatment to help in the battle against the daily dose of bacteria that we can not escape.
Read more >>

MouSelect Protein A binding test

Purification on Protein A is the most common method for purification of antibodies, especially in the later phases of pharmaceutical development. The MouSelect kit are designed to aid in an early selection of polyclonal or monoclonal antibodies, to a preferential purification on Protein A.

The information of an early screening will save valuable time down-stream, since products have already been preferentially selected towards later Protein A purification. Screening on-column or in pre-filled filter plates is more time consuming and expensive, and this procedure is generally not possible for a large number of antibodies.

Protein A ELISA

Our Protein A ELISA is specific, highly sensitive and designed to detect protein A contamination in samples with high amount of antibodies.

The Protein A ELISA is typically used by antibody manufacturers and protein A matrix producers for quality control to monitor protein A leakage during purification.